153 related articles for article (PubMed ID: 24846709)
1. A mechanistic approach to understanding oral drug absorption in pediatrics: an overview of fundamentals.
Debotton N; Dahan A
Drug Discov Today; 2014 Sep; 19(9):1322-36. PubMed ID: 24846709
[TBL] [Abstract][Full Text] [Related]
2. Optimizing pediatric dosing: a developmental pharmacologic approach.
Anderson GD; Lynn AM
Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
[TBL] [Abstract][Full Text] [Related]
3. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
4. Developmental pharmacology--drug disposition, action, and therapy in infants and children.
Kearns GL; Abdel-Rahman SM; Alander SW; Blowey DL; Leeder JS; Kauffman RE
N Engl J Med; 2003 Sep; 349(12):1157-67. PubMed ID: 13679531
[No Abstract] [Full Text] [Related]
5. Ontogeny of oral drug absorption processes in children.
Mooij MG; de Koning BA; Huijsman ML; de Wildt SN
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1293-303. PubMed ID: 22686526
[TBL] [Abstract][Full Text] [Related]
6. Knowledge-driven approaches for the guidance of first-in-children dosing.
Edginton AN
Paediatr Anaesth; 2011 Mar; 21(3):206-13. PubMed ID: 21129100
[TBL] [Abstract][Full Text] [Related]
7. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
8. In vivo rat PK profiling in drug discovery: new challenges.
Zonzini L; Bianchi F; Cesari N; Sartori M
Expert Opin Drug Discov; 2010 Nov; 5(11):1031-7. PubMed ID: 22827743
[TBL] [Abstract][Full Text] [Related]
9. In vitro-in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications.
Cho HJ; Kim JE; Kim DD; Yoon IS
Drug Dev Ind Pharm; 2014 Aug; 40(8):989-98. PubMed ID: 23981203
[TBL] [Abstract][Full Text] [Related]
10. Influence of covariance between random effects in design for nonlinear mixed-effect models with an illustration in pediatric pharmacokinetics.
Dumont C; Chenel M; Mentré F
J Biopharm Stat; 2014; 24(3):471-92. PubMed ID: 24697342
[TBL] [Abstract][Full Text] [Related]
11. An update on computational oral absorption simulation.
Dressman JB; Thelen K; Willmann S
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1345-64. PubMed ID: 21939427
[TBL] [Abstract][Full Text] [Related]
12. Allometry Is a Reasonable Choice in Pediatric Drug Development.
Liu T; Ghafoori P; Gobburu JV
J Clin Pharmacol; 2017 Apr; 57(4):469-475. PubMed ID: 27649629
[TBL] [Abstract][Full Text] [Related]
13. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
14. Failed Pediatric Drug Development Trials.
Momper JD; Mulugeta Y; Burckart GJ
Clin Pharmacol Ther; 2015 Sep; 98(3):245-51. PubMed ID: 25963725
[TBL] [Abstract][Full Text] [Related]
15. Pediatric critical care pharmacodynamics.
Dionne R; McManus C
Crit Care Nurs Clin North Am; 1993 Jun; 5(2):367-75. PubMed ID: 8398042
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological research in pediatrics: From neonates to adolescents.
Rakhmanina NY; van den Anker JN
Adv Drug Deliv Rev; 2006 Apr; 58(1):4-14. PubMed ID: 16533543
[TBL] [Abstract][Full Text] [Related]
17. Paediatric oral biopharmaceutics: key considerations and current challenges.
Batchelor HK; Fotaki N; Klein S
Adv Drug Deliv Rev; 2014 Jun; 73():102-26. PubMed ID: 24189013
[TBL] [Abstract][Full Text] [Related]
18. A new paradigm for improving oral absorption of drugs in discovery: role of physicochemical properties, different excipients and the pharmaceutical scientist.
Wilson AG; Nouraldeen A; Gopinathan S
Future Med Chem; 2010 Jan; 2(1):1-5. PubMed ID: 21426039
[No Abstract] [Full Text] [Related]
19. Toward a new age of cellular pharmacokinetics in drug discovery.
Zhou F; Zhang J; Li P; Niu F; Wu X; Wang G; Roberts MS
Drug Metab Rev; 2011 Aug; 43(3):335-45. PubMed ID: 21395404
[TBL] [Abstract][Full Text] [Related]
20. Improving oral absorption via drug-loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication.
Shahbazi MA; Santos HA
Curr Drug Metab; 2013 Jan; 14(1):28-56. PubMed ID: 22497568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
